Lymphoscintigraphy is a non-invasive nuclear medicine imaging technique widely utilized in diagnosing and assessing lymphedema by visualizing lymphatic function after subcutaneous injection of radiopharmaceuticals. Accurate interpretation of lymphoscintigraphy is essential, as it directly impacts clinical decision-making, patient prognosis prediction, and assessment of therapeutic response. However, variability in interpretation criteria and quantitative assessments among institutions has led to inconsistency in clinical application and challenges in treatment planning. To address these issues, the Korean Society of Nuclear Medicine and the Korean Society of Lymphedema have collaboratively developed a procedure and interpretation guideline, reflecting current clinical practices and the availability of 99mTc-phytate in the Republic of Korea. This guideline specifically focuses on the standardized qualitative and quantitative criteria for lymphoscintigraphic interpretation, outlines normal and abnormal imaging findings, and discusses interpretation standards according to clinical indication followed by previous Part I. Adoption of this guideline aims to improve the consistency of interpretations, facilitate more effective clinical management strategies, and ultimately enhance the quality of care provided to patients with lymphedema.
Suh et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: